搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
腾讯网
21 小时
多名患者脑部肿瘤缩小!潜在重磅ADC获突破性疗法认定
此次FDA授予突破性疗法认定主要是基于TROPION-Lung05临床2期试验数据,并加上TROPION-Lung01临床3期试验的支持性数据。今年美国临床肿瘤学会(ASCO)年会中所公布的TROPION-Lung05试验的部分结果显示,18名具有目 ...
Yahoo Finance
1 天
ASH 2024: AstraZeneca set to take a BiTE out of follicular lymphoma market
At the 2024 annual meeting of the American Society of Hematology (ASH), held on 7 December in San Diego, California, ...
BioPharma Dive
3 小时
ASH24: Leukemia drug sequencing, sickle cell questions and a new kind of CAR-T
Data from Eli Lilly and AstraZeneca could help doctors decide treatment order in chronic lymphocytic leukemia. Elsewhere, ...
FiercePharma
2 天
ASH: AstraZeneca proposes fixed-duration Calquence combos in chronic lymphocytic leukemia
Trying to break from the decade-old practice of using BTK inhibitors indefinitely to treat blood cancer, AstraZeneca has ...
ENDPOINTS NEWS
1 天
AstraZeneca reveals first clinical data for bispecific T cell engager ...
AstraZeneca is getting ready to step on the gas in the world of bispecific T cell engagers. The company presented some of its ...
5 天
FDA approves AstraZeneca's Imfinzi for limited-stage small cell lung cancer
The U.S. Food and Drug Administration has approved AstraZeneca blockbuster drug Imfinzi to treat some adults with ...
FiercePharma
5 天
AstraZeneca scores FDA nod for Imfinzi as first immunotherapy for limited-stage small cell ...
AstraZeneca has picked off another label expansion for its cancer blockbuster Imfinzi (durvalumab) as the FDA has ...
Zacks.com on MSN
6 小时
AZN, Daiichi's ADC Gets FDA Breakthrough Tag for EGFR-Mutated NSCLC
AstraZeneca AZN and its Japanese partner Daiichi Sankyo announced that the FDA has granted a Breakthrough Therapy designation ...
FierceBiotech
4 天
AstraZeneca, Daiichi share data behind Dato-DXd do-over amid 2nd bid for lung cancer approval
AstraZeneca and Daiichi Sankyo have shared the data they believe can secure approval for datopotamab deruxtecan (Dato-DXd) at ...
WebMD
1 天
FDA Approves Drug for Aggressive Small-Cell Lung Cancer
The FDA has approved the drug durvalumab for adults with limited-stage small-cell lung cancer (LS-SCLC) whose disease hasn’t gotten worse after getting platinum-based chemo and radiation at the same ...
Daily
4 天
AstraZeneca Imfinzi gets USFDA nod for limited-stage small cell lung cancer
AstraZeneca's Imfinzi (durvalumab) has been approved in the US for the treatment of adult patients with limited-stage small ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈